位置:首页 > 蛋白库 > PDXH_ECOLI
PDXH_ECOLI
ID   PDXH_ECOLI              Reviewed;         218 AA.
AC   P0AFI7; P28225;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   03-AUG-2022, entry version 134.
DE   RecName: Full=Pyridoxine/pyridoxamine 5'-phosphate oxidase;
DE            EC=1.4.3.5 {ECO:0000269|PubMed:11786019, ECO:0000269|PubMed:7860596, ECO:0000269|PubMed:9693059};
DE   AltName: Full=PNP/PMP oxidase;
DE            Short=PNPOx;
DE   AltName: Full=Pyridoxal 5'-phosphate synthase;
GN   Name=pdxH; OrderedLocusNames=b1638, JW1630;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=1356963; DOI=10.1128/jb.174.19.6033-6045.1992;
RA   Lam H.-M., Winkler M.E.;
RT   "Characterization of the complex pdxH-tyrS operon of Escherichia coli K-12
RT   and pleiotropic phenotypes caused by pdxH insertion mutations.";
RL   J. Bacteriol. 174:6033-6045(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9097039; DOI=10.1093/dnares/3.6.363;
RA   Aiba H., Baba T., Fujita K., Hayashi K., Inada T., Isono K., Itoh T.,
RA   Kasai H., Kashimoto K., Kimura S., Kitakawa M., Kitagawa M., Makino K.,
RA   Miki T., Mizobuchi K., Mori H., Mori T., Motomura K., Nakade S.,
RA   Nakamura Y., Nashimoto H., Nishio Y., Oshima T., Saito N., Sampei G.,
RA   Seki Y., Sivasundaram S., Tagami H., Takeda J., Takemoto K., Takeuchi Y.,
RA   Wada C., Yamamoto Y., Horiuchi T.;
RT   "A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to
RT   the 28.0-40.1 min region on the linkage map.";
RL   DNA Res. 3:363-377(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-11, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, COFACTOR, AND SUBUNIT.
RC   STRAIN=K12;
RX   PubMed=7860596; DOI=10.1128/jb.177.4.883-891.1995;
RA   Zhao G., Winkler M.E.;
RT   "Kinetic limitation and cellular amount of pyridoxine (pyridoxamine) 5'-
RT   phosphate oxidase of Escherichia coli K-12.";
RL   J. Bacteriol. 177:883-891(1995).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, AND
RP   SUBUNIT.
RX   PubMed=9693059; DOI=10.1006/prep.1998.0904;
RA   di Salvo M., Yang E., Zhao G., Winkler M.E., Schirch V.;
RT   "Expression, purification, and characterization of recombinant Escherichia
RT   coli pyridoxine 5'-phosphate oxidase.";
RL   Protein Expr. Purif. 13:349-356(1998).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 20-218 IN COMPLEX WITH FMN,
RP   COFACTOR, AND SUBUNIT.
RX   PubMed=10903950; DOI=10.1016/s0969-2126(00)00162-3;
RA   Safo M.K., Mathews I., Musayev F.N., di Salvo M.L., Thiel D.J.,
RA   Abraham D.J., Schirch V.;
RT   "X-ray structure of Escherichia coli pyridoxine 5'-phosphate oxidase
RT   complexed with FMN at 1.8-A resolution.";
RL   Structure 8:751-762(2000).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEXES WITH PYRIDOXAL
RP   5'-PHOSPHATE AND FMN, COFACTOR, AND SUBUNIT.
RX   PubMed=11453690; DOI=10.1006/jmbi.2001.4734;
RA   Safo M.K., Musayev F.N., di Salvo M.L., Schirch V.;
RT   "X-ray structure of Escherichia coli pyridoxine 5'-phosphate oxidase
RT   complexed with pyridoxal 5'-phosphate at 2.0 A resolution.";
RL   J. Mol. Biol. 310:817-826(2001).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL
RP   5'-PHOSPHATE AND FMN, FUNCTION, CATALYTIC ACTIVITY, SUBUNIT,
RP   BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF ARG-14; TYR-17; ASP-49;
RP   ARG-197 AND HIS-199, AND COFACTOR.
RX   PubMed=11786019; DOI=10.1006/jmbi.2001.5254;
RA   di Salvo M.L., Ko T.-P., Musayev F.N., Raboni S., Schirch V., Safo M.K.;
RT   "Active site structure and stereospecificity of Escherichia coli
RT   pyridoxine-5'-phosphate oxidase.";
RL   J. Mol. Biol. 315:385-397(2002).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL
RP   5'-PHOSPHATE AND FMN, COFACTOR, AND SUBUNIT.
RX   PubMed=15858270; DOI=10.1107/s0907444905005512;
RA   Safo M.K., Musayev F.N., Schirch V.;
RT   "Structure of Escherichia coli pyridoxine 5'-phosphate oxidase in a
RT   tetragonal crystal form: insights into the mechanistic pathway of the
RT   enzyme.";
RL   Acta Crystallogr. D 61:599-604(2005).
CC   -!- FUNCTION: Catalyzes the oxidation of either pyridoxine 5'-phosphate
CC       (PNP) or pyridoxamine 5'-phosphate (PMP) into pyridoxal 5'-phosphate
CC       (PLP). {ECO:0000269|PubMed:11786019, ECO:0000269|PubMed:7860596,
CC       ECO:0000269|PubMed:9693059}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O2 + pyridoxamine 5'-phosphate = H2O2 + NH4(+) +
CC         pyridoxal 5'-phosphate; Xref=Rhea:RHEA:15817, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:58451, ChEBI:CHEBI:597326; EC=1.4.3.5;
CC         Evidence={ECO:0000269|PubMed:11786019, ECO:0000269|PubMed:7860596,
CC         ECO:0000269|PubMed:9693059};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + pyridoxine 5'-phosphate = H2O2 + pyridoxal 5'-phosphate;
CC         Xref=Rhea:RHEA:15149, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:58589, ChEBI:CHEBI:597326; EC=1.4.3.5;
CC         Evidence={ECO:0000269|PubMed:11786019, ECO:0000269|PubMed:7860596,
CC         ECO:0000269|PubMed:9693059};
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000269|PubMed:10903950, ECO:0000269|PubMed:11453690,
CC         ECO:0000269|PubMed:11786019, ECO:0000269|PubMed:15858270,
CC         ECO:0000269|PubMed:7860596, ECO:0000269|PubMed:9693059};
CC       Note=Binds 1 FMN per subunit. {ECO:0000269|PubMed:10903950,
CC       ECO:0000269|PubMed:11453690, ECO:0000269|PubMed:11786019,
CC       ECO:0000269|PubMed:15858270, ECO:0000269|PubMed:7860596,
CC       ECO:0000269|PubMed:9693059};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.3 uM for pyridoxamine 5'-phosphate
CC         {ECO:0000269|PubMed:11786019};
CC         KM=2 uM for pyridoxine 5'-phosphate (at pH 7.6 and 37 degrees
CC         Celsius) {ECO:0000269|PubMed:7860596, ECO:0000269|PubMed:9693059};
CC         KM=105 uM for pyridoxamine 5'-phosphate (at pH 7.6 and 37 degrees
CC         Celsius) {ECO:0000269|PubMed:7860596};
CC         Note=kcat is 0.3 sec(-1) for oxidase activity with pyridoxine 5'-
CC         phosphate as substrate (at pH 7.6 and 37 degrees Celsius).
CC         {ECO:0000269|PubMed:9693059};
CC   -!- PATHWAY: Cofactor metabolism; pyridoxal 5'-phosphate salvage; pyridoxal
CC       5'-phosphate from pyridoxamine 5'-phosphate: step 1/1.
CC   -!- PATHWAY: Cofactor metabolism; pyridoxal 5'-phosphate salvage; pyridoxal
CC       5'-phosphate from pyridoxine 5'-phosphate: step 1/1.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:10903950,
CC       ECO:0000269|PubMed:11453690, ECO:0000269|PubMed:11786019,
CC       ECO:0000269|PubMed:15858270, ECO:0000269|PubMed:7860596,
CC       ECO:0000269|PubMed:9693059}.
CC   -!- MISCELLANEOUS: Can bind a second molecule of pyridoxamine 5'-phosphate
CC       at a non-catalytic site in a cleft at the protein surface.
CC   -!- SIMILARITY: Belongs to the pyridoxamine 5'-phosphate oxidase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M92351; AAA24709.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC74710.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA15399.1; -; Genomic_DNA.
DR   PIR; B43261; B43261.
DR   RefSeq; NP_416155.1; NC_000913.3.
DR   RefSeq; WP_001282319.1; NZ_STEB01000003.1.
DR   PDB; 1DNL; X-ray; 1.80 A; A=20-218.
DR   PDB; 1G76; X-ray; 2.20 A; A=1-218.
DR   PDB; 1G77; X-ray; 2.10 A; A=1-218.
DR   PDB; 1G78; X-ray; 2.20 A; A=1-218.
DR   PDB; 1G79; X-ray; 2.00 A; A=1-218.
DR   PDB; 1JNW; X-ray; 2.07 A; A=1-218.
DR   PDB; 1WV4; X-ray; 2.60 A; A/B=1-218.
DR   PDB; 6YLZ; X-ray; 1.56 A; AAA=1-218.
DR   PDB; 6YMH; X-ray; 2.42 A; AAA/BBB=1-218.
DR   PDBsum; 1DNL; -.
DR   PDBsum; 1G76; -.
DR   PDBsum; 1G77; -.
DR   PDBsum; 1G78; -.
DR   PDBsum; 1G79; -.
DR   PDBsum; 1JNW; -.
DR   PDBsum; 1WV4; -.
DR   PDBsum; 6YLZ; -.
DR   PDBsum; 6YMH; -.
DR   AlphaFoldDB; P0AFI7; -.
DR   SMR; P0AFI7; -.
DR   BioGRID; 4263488; 16.
DR   BioGRID; 851147; 1.
DR   DIP; DIP-48024N; -.
DR   IntAct; P0AFI7; 13.
DR   STRING; 511145.b1638; -.
DR   DrugBank; DB03247; Flavin mononucleotide.
DR   DrugBank; DB03345; Mercaptoethanol.
DR   jPOST; P0AFI7; -.
DR   PaxDb; P0AFI7; -.
DR   PRIDE; P0AFI7; -.
DR   EnsemblBacteria; AAC74710; AAC74710; b1638.
DR   EnsemblBacteria; BAA15399; BAA15399; BAA15399.
DR   GeneID; 58462440; -.
DR   GeneID; 946806; -.
DR   KEGG; ecj:JW1630; -.
DR   KEGG; eco:b1638; -.
DR   PATRIC; fig|1411691.4.peg.622; -.
DR   EchoBASE; EB1450; -.
DR   eggNOG; COG0259; Bacteria.
DR   InParanoid; P0AFI7; -.
DR   OMA; PEPNAMV; -.
DR   PhylomeDB; P0AFI7; -.
DR   BioCyc; EcoCyc:PDXH-MON; -.
DR   BioCyc; MetaCyc:PDXH-MON; -.
DR   BRENDA; 1.4.3.5; 2026.
DR   SABIO-RK; P0AFI7; -.
DR   UniPathway; UPA01068; UER00304.
DR   UniPathway; UPA01068; UER00305.
DR   EvolutionaryTrace; P0AFI7; -.
DR   PRO; PR:P0AFI7; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0032991; C:protein-containing complex; IDA:CAFA.
DR   GO; GO:0010181; F:FMN binding; IDA:EcoCyc.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:EcoliWiki.
DR   GO; GO:0042301; F:phosphate ion binding; IDA:CAFA.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:CAFA.
DR   GO; GO:0004733; F:pyridoxamine-phosphate oxidase activity; IDA:EcoCyc.
DR   GO; GO:1902444; F:riboflavin binding; IDA:CAFA.
DR   GO; GO:0036001; P:'de novo' pyridoxal 5'-phosphate biosynthetic process; IMP:EcoCyc.
DR   GO; GO:0042823; P:pyridoxal phosphate biosynthetic process; IBA:GO_Central.
DR   GO; GO:0008615; P:pyridoxine biosynthetic process; IEA:UniProtKB-KW.
DR   Gene3D; 2.30.110.10; -; 1.
DR   HAMAP; MF_01629; PdxH; 1.
DR   InterPro; IPR000659; Pyridox_Oxase.
DR   InterPro; IPR019740; Pyridox_Oxase_CS.
DR   InterPro; IPR011576; Pyridox_Oxase_put.
DR   InterPro; IPR019576; Pyridoxamine_oxidase_dimer_C.
DR   InterPro; IPR012349; Split_barrel_FMN-bd.
DR   PANTHER; PTHR10851; PTHR10851; 1.
DR   Pfam; PF10590; PNP_phzG_C; 1.
DR   Pfam; PF01243; Putative_PNPOx; 1.
DR   PIRSF; PIRSF000190; Pyd_amn-ph_oxd; 1.
DR   TIGRFAMs; TIGR00558; pdxH; 1.
DR   PROSITE; PS01064; PYRIDOX_OXIDASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Flavoprotein; FMN; Oxidoreductase;
KW   Pyridoxine biosynthesis; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:7860596"
FT   CHAIN           2..218
FT                   /note="Pyridoxine/pyridoxamine 5'-phosphate oxidase"
FT                   /id="PRO_0000167706"
FT   BINDING         14..17
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:11786019"
FT   BINDING         67..72
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:10903950,
FT                   ECO:0000269|PubMed:11453690, ECO:0000269|PubMed:15858270"
FT   BINDING         72
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:11453690"
FT   BINDING         82..83
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:10903950,
FT                   ECO:0000269|PubMed:11453690, ECO:0000269|PubMed:15858270"
FT   BINDING         88
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:10903950,
FT                   ECO:0000269|PubMed:11453690, ECO:0000269|PubMed:15858270"
FT   BINDING         89
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:10903950,
FT                   ECO:0000269|PubMed:11453690, ECO:0000269|PubMed:15858270"
FT   BINDING         111
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:11786019,
FT                   ECO:0000269|PubMed:15858270"
FT   BINDING         129
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:11453690"
FT   BINDING         133
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:11453690"
FT   BINDING         137
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:11453690"
FT   BINDING         146..147
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:10903950,
FT                   ECO:0000269|PubMed:11453690, ECO:0000269|PubMed:15858270"
FT   BINDING         191
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:15858270"
FT   BINDING         197..199
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:11786019"
FT   BINDING         201
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:11786019,
FT                   ECO:0000269|PubMed:15858270"
FT   MUTAGEN         14
FT                   /note="R->E: Reduces affinity for substrate about 7-fold,
FT                   but has no effect on catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:11786019"
FT   MUTAGEN         14
FT                   /note="R->M: Reduces affinity for substrate about 9-fold,
FT                   but has no effect on catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:11786019"
FT   MUTAGEN         17
FT                   /note="Y->F: Reduces affinity for substrate 3-fold, but has
FT                   about 5-fold increase in catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:11786019"
FT   MUTAGEN         49
FT                   /note="D->A: Reduces affinity for substrate 3-fold and
FT                   catalytic activity 2-fold."
FT                   /evidence="ECO:0000269|PubMed:11786019"
FT   MUTAGEN         197
FT                   /note="R->E: Reduces affinity for substrate 8000-fold and
FT                   catalytic activity 16-fold."
FT                   /evidence="ECO:0000269|PubMed:11786019"
FT   MUTAGEN         197
FT                   /note="R->M: Reduces affinity for substrate 300-fold and
FT                   catalytic activity about 4-fold."
FT                   /evidence="ECO:0000269|PubMed:11786019"
FT   MUTAGEN         199
FT                   /note="H->A: Reduces affinity for substrate 230-fold, but
FT                   has no effect on catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:11786019"
FT   MUTAGEN         199
FT                   /note="H->N: Reduces catalytic activity about 4-fold, but
FT                   has no effect on affinity for substrate."
FT                   /evidence="ECO:0000269|PubMed:11786019"
FT   HELIX           9..12
FT                   /evidence="ECO:0007829|PDB:1JNW"
FT   HELIX           24..26
FT                   /evidence="ECO:0007829|PDB:1DNL"
FT   HELIX           31..44
FT                   /evidence="ECO:0007829|PDB:1DNL"
FT   STRAND          52..58
FT                   /evidence="ECO:0007829|PDB:1DNL"
FT   STRAND          64..70
FT                   /evidence="ECO:0007829|PDB:1DNL"
FT   STRAND          73..75
FT                   /evidence="ECO:0007829|PDB:1DNL"
FT   STRAND          78..84
FT                   /evidence="ECO:0007829|PDB:1DNL"
FT   HELIX           88..95
FT                   /evidence="ECO:0007829|PDB:1DNL"
FT   STRAND          98..103
FT                   /evidence="ECO:0007829|PDB:1DNL"
FT   HELIX           106..108
FT                   /evidence="ECO:0007829|PDB:1DNL"
FT   STRAND          110..120
FT                   /evidence="ECO:0007829|PDB:1DNL"
FT   HELIX           123..130
FT                   /evidence="ECO:0007829|PDB:1DNL"
FT   HELIX           135..143
FT                   /evidence="ECO:0007829|PDB:1DNL"
FT   HELIX           154..166
FT                   /evidence="ECO:0007829|PDB:1DNL"
FT   STRAND          167..170
FT                   /evidence="ECO:0007829|PDB:1G79"
FT   STRAND          178..183
FT                   /evidence="ECO:0007829|PDB:1DNL"
FT   STRAND          186..192
FT                   /evidence="ECO:0007829|PDB:1DNL"
FT   HELIX           195..197
FT                   /evidence="ECO:0007829|PDB:1DNL"
FT   STRAND          200..206
FT                   /evidence="ECO:0007829|PDB:1DNL"
FT   STRAND          208..215
FT                   /evidence="ECO:0007829|PDB:1DNL"
SQ   SEQUENCE   218 AA;  25545 MW;  8B47CEEEA6CEF5F9 CRC64;
     MSDNDELQQI AHLRREYTKG GLRRRDLPAD PLTLFERWLS QACEAKLADP TAMVVATVDE
     HGQPYQRIVL LKHYDEKGMV FYTNLGSRKA HQIENNPRVS LLFPWHTLER QVMVIGKAER
     LSTLEVMKYF HSRPRDSQIG AWVSKQSSRI SARGILESKF LELKQKFQQG EVPLPSFWGG
     FRVSLEQIEF WQGGEHRLHD RFLYQRENDA WKIDRLAP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024